Pennsylvania Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
ATO
Pennsylvania Capital Management's MRK Position: Q2 2026 in Review
Pennsylvania Capital Management increased its Merck (MRK) stake by 6% in Q2 2026, buying an estimated $12.9K and bringing the position to 1,945 shares worth $250K. The position accounts for 0.06% of the portfolio, ranked #110.
Pennsylvania Capital Management first reported a position in MRK in Q4 2019 and has held it in 25 quarters since. The position peaked at $674K in Q4 2019. 1,562 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Pennsylvania Capital Management held 1,945 shares of Merck worth $250K as of Q2 2026.
- Pennsylvania Capital Management bought 110 Merck shares in Q2 2026, an estimated $12.9K.
- Merck made up 0.06% of Pennsylvania Capital Management's portfolio in Q2 2026, its #110 holding.
- Pennsylvania Capital Management first reported a position in Merck in Q4 2019 and has held it in 25 quarters since.
- Pennsylvania Capital Management's Merck position peaked at $674K in Q4 2019.
- 1,562 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Pennsylvania Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.